Joseph Chedrawe Joins V&E’s Dispute Resolution Practice in Dubai

DUBAI, Sept. 25, 2017 /PRNewswire/ — Vinson & Elkins continues to expand its Middle East disputes presence with the addition of Joseph Chedrawe as counsel in the firm’s Dubai office.

Chedrawe comes to V&E from Freshfields Bruckhaus Deringer, where he represented multinational corporations, governments and private clients across multiple industries in commercial arbitrations, with a focus on construction and engineering and commercial disputes. He joins V&E partner Amir Ghaffari, who transferred to Dubai in March to lead the firm’s growing International Dispute Resolution practice in the region.

“Dubai is a major center of disputes emanating from the energy and construction and engineering sectors, which in turn is driving the demand for legal services in the Middle East,” said James Loftis, head of V&E’s global International Dispute Resolution practice. “Joseph is an outstanding lawyer with significant experience handling these types of complex disputes in the region. We are pleased to welcome him to V&E’s IDR practice.”

Chedrawe has acted as counsel in more than 20 international construction and commercial disputes under many of the major arbitral institutions, as well as in ad-hoc proceedings. His particular experience includes disputes relating to power and water facilities, government service contracts,  public-private partnerships, housing developments, telecommunications, mergers and acquisitions, joint ventures and oil and gas production.

Among his notable representations, Chedrawe has advised a Japanese and South Korean engineering and construction consortium in an arbitration regarding a multibillion dollar fertilizer complex in North Africa. He has also advised government entities in the Gulf on several matters, including disputes relating to a multibillion dollar independent water and power plant, the termination of a waste management contract and the construction of a major housing project.

Chedrawe has appeared several times as an advocate in litigation and arbitration proceedings. He is an advocate of the Dubai International Financial Centre courts and has sat as a party-appointed and sole arbitrator. Before settling in the Middle East, Chedrawe worked in Canada, South Africa and the United Kingdom, where he was a lecturer in law at the University of Oxford.

“This is an exciting time in the region, with a number of strategic developments being implemented in both the public and private sectors,” Chedrawe said. “As a leading global firm, V&E handles some of the most important disputes globally and in the Middle East. I am thrilled to be joining such an impressive team of international dispute resolution practitioners.”

V&E’s International Dispute Resolution and Arbitration practice is among the world’s best, receiving international recognition in Chambers & Partners (2017), Legal 500 (2017) and as a member of the Global Arbitration Review 100 (2017). The firm has represented clients in the energy, infrastructure development and construction, technology/intellectual property, insurance, banking and pharmaceuticals sectors in more than 60 countries, in virtually every common arbitral venue, and under all major international and regional rules systems.

Celebrating its 100th year, Vinson & Elkins LLP is an international law firm with approximately 700 lawyers across 16 offices worldwide. For more information, please contact Jeremy Heallen at +1.713.758.2079 or Courtney Binick at +1.713.758.2333.

DIFC
Gate Village 10, Office 211
P.O. Box 504945
Dubai, United Arab Emirates
+971.4.330.1800
www.velaw.com

This communication may be considered advertising under law regulating the use of e-mail. This communication is provided by Vinson & Elkins LLP for educational and informational purposes only and is not intended, nor should it be construed, as legal advice.

Related Post
جينيف، سويسرا، 20 أكتوبر 2017 /PRNewswire/ — ترقق العظام هو مرض خفي لا يخلو من
مرفق الشركة كارلسبادفي الولايات المتحدة يجتاز تفتيش إدارة الغذاء والدواء الأميركية وهيئة ترخيص الدواء في
الشركة تتوقع أرباحا صافية بما بين 4.3-4.8 مليار يوان للعام كله شنجن، الصين، 19 تشرين